Therapeutic Asset Ratings
1,553 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Misoprostol
Constipation Disorder
Montefiore Medical Center
Early P1
C
(39)
Misoprostol
Distension
Montefiore Medical Center
Early P1
C
(39)
Misoprostol
Gas Bloat Syndrome
Montefiore Medical Center
Early P1
C
(39)
Misoprostol
Pregnancy Disorder
University of Maryland, Baltimore
Early P1
C
(39)
Mitoxantrone
Neoantigen
BGI, China
Early P1
C
(39)
MONOCLONAL ANTIBODY BC8
B ALL
Memorial Sloan Kettering Cancer Center
Early P1
C
(39)
MONOCLONAL ANTIBODY BC8
B-Cell Acute Lymphoblastic Leukemia
Memorial Sloan Kettering Cancer Center
Early P1
C
(39)
MONOCLONAL ANTIBODY BC8
Diffuse Large B-Cell Lymphoma Activated B-Cell Type
Memorial Sloan Kettering Cancer Center
Early P1
C
(39)
MONOCLONAL ANTIBODY BC8
Diffuse Large B-Cell Lymphoma With Chronic Inflammation
Memorial Sloan Kettering Cancer Center
Early P1
C
(39)
MONOCLONAL ANTIBODY BC8
Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type
Memorial Sloan Kettering Cancer Center
Early P1
C
(39)
MONOCLONAL ANTIBODY BC8
High Grade B-Cell Lymphoma
Memorial Sloan Kettering Cancer Center
Early P1
C
(39)
MONOMETHYL AURISTATIN E
Malignant Pancreatic Neoplasm
The First Affiliated Hospital of Air Force Medicial University
Early P1
C
(39)
Monomethyl Fumarate
B Cell Leukemia
Wondercel Biotech (ShenZhen)
Early P1
C
(39)
Monomethyl Fumarate
B Cell Malignancy
Wondercel Biotech (ShenZhen)
Early P1
C
(39)
Montelukast
Brain Neoplasm
University of South Florida
Early P1
C
(39)
Mrna-2752
Ductal Breast Carcinoma In Situ
Laura Esserman
Early P1
C
(39)
M-SYMPATHOL
Vasoconstriction
University of Missouri-Columbia
Early P1
C
(39)
M-SYMPATHOL
Vasodilation
University of Missouri-Columbia
Early P1
C
(39)
Murine Cd19 Car-T Cells
Non-Hodgkin Lymphoma
Zhejiang University
Early P1
C
(39)
NADOLOL
CAR T-Cell Therapy
University of Arizona
Early P1
C
(39)
NADOLOL
Donor Lymphocyte Infusion
University of Arizona
Early P1
C
(39)
NADOLOL
Disease Related To Hematopoietic Stem Cell Transplant
University of Arizona
Early P1
C
(39)
Nextgen-Til
Carcinoma
Vall d'Hebron Institute of Oncology
Early P1
C
(39)
Nicotinamide Ribonucleoside
Cognitive Disorder
Mclean Hospital
Early P1
C
(39)
Niraparib
Sarcoma
OHSU Knight Cancer Institute
Early P1
C
(39)
Showing 651 to 675 of 1,553 assets
Previous
Page 27 of 63
Next
